Skip to content

Clinical trials

Completed Phase 2 Pulmonary Embolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Phase: Phase 2 Status: Completed Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20052
20062
20073
20081
20091
20131
20151
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Utah3
Bayer2
GlaxoSmithKline2
Agen Biomedical1
Bristol-Myers Squibb1
Crux Biomedical1
Daiichi Sankyo1
Indiana University1
Medical University of Vienna1
University Hospital, Geneva1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism15
Venous Thrombosis8
Venous Thromboembolism6
Thrombosis4
Embolism2
Embolism and Thrombosis2
Acquired Immunodeficiency Syndrome1
Atrial Fibrillation1
Cardiovascular Diseases1
Lung Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.